Back to funds

venBio Partners LLC

Updated 6 days ago

Managed by Venbio Partners Llc • Latest filing Q3 2026

Portfolio value
$495.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$216.3M
Q1 2026$280.6M
Q2 2026$519.4M
Q3 2026$495.9M

Top holdings

9 positions as of Q3 2026

View filing
P

PARABILIS MEDICINES INC

Value
$170.1M
Shares
5.27M
% Port
34.29%
P

PHARVARIS N V

Value
$141.4M
Shares
4.46M
% Port
28.52%
?
3.N/A

ATTOVIA THERAPEUTICS INC

Value
$71.7M
Shares
4.18M
% Port
14.45%
A

ACHIEVE LIFE SCIENCE INC

Value
$47.9M
Shares
5.91M
% Port
9.65%
A

ALUMIS INC

Value
$31M
Shares
4.19M
% Port
6.25%
A

ALX ONCOLOGY HLDGS INC

Value
$17.9M
Shares
12.88M
% Port
3.61%
Y

YARROW BIOSCIENCE INC

Value
$12.5M
Shares
554.8K
% Port
2.52%
L

LYELL IMMUNOPHARMA INC

Value
$3.3M
Shares
337.7K
% Port
0.67%
?
9.N/A

LISATA THERAPEUTICS INC

Value
$225K
Shares
156.5K
% Port
0.05%

Explore